Legal Representation
Attorney
Malaika D. Tyson
USPTO Deadlines
Next Deadline
192 days remaining
NOA E-Mailed - SOU Required
Due Date
August 12, 2026
Extension Available
Until February 12, 2027
Application History
22 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Dec 12, 2025 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Dec 11, 2025 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
| Dec 11, 2025 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
| Dec 11, 2025 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Dec 10, 2025 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
| Dec 10, 2025 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | Loading... |
| Dec 10, 2025 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | Loading... |
| Aug 12, 2025 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Jun 17, 2025 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Jun 17, 2025 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Jun 11, 2025 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| May 13, 2025 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Apr 8, 2025 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Apr 8, 2025 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Apr 8, 2025 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Mar 10, 2025 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Mar 10, 2025 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Mar 10, 2025 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Mar 3, 2025 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Feb 26, 2025 | MDSC | E | NOTICE OF DESIGN SEARCH CODE E-MAILED | Loading... |
| Feb 26, 2025 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Aug 26, 2024 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Pharmaceutical products for the prevention and treatment of cancer and autoimmune disorders; therapeutic pharmaceuticals for the treatment of cancer and autoimmune disorders; anti-cancer preparations being anti-cancer medicines comprised of small molecules and biologics; pharmaceuticals and therapeutic pharmaceuticals for the treatment of cancer and autoimmune disorders and for use in the fields of oncology and immunology
Class 042
Pharmaceutical research and development; scientific research and development; medical research and development in the fields of oncology, autoimmunity, and immunology; medical research and development services in the fields of drug discovery and oncology, autoimmunity, and immunology
Additional Information
Design Mark
The mark consists of a wing in variations of blue, turquoise, green, and yellow.
Color Claim
The color(s) blue, turquoise, green, and yellow is/are claimed as a feature of the mark.
Classification
International Classes
005
042